These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Selective CD4+ T cell help for antibody responses to a large viral pathogen: deterministic linkage of specificities. Sette A; Moutaftsi M; Moyron-Quiroz J; McCausland MM; Davies DH; Johnston RJ; Peters B; Rafii-El-Idrissi Benhnia M; Hoffmann J; Su HP; Singh K; Garboczi DN; Head S; Grey H; Felgner PL; Crotty S Immunity; 2008 Jun; 28(6):847-58. PubMed ID: 18549802 [TBL] [Abstract][Full Text] [Related]
5. Single-shot immunization with recombinant adenovirus encoding vaccinia virus glycoprotein A27L is protective against a virulent respiratory poxvirus infection. Rudraraju R; Ramsay AJ Vaccine; 2010 Jul; 28(31):4997-5004. PubMed ID: 20653083 [TBL] [Abstract][Full Text] [Related]
6. GM-CSF production allows the identification of immunoprevalent antigens recognized by human CD4+ T cells following smallpox vaccination. Judkowski V; Bunying A; Ge F; Appel JR; Law K; Sharma A; Raja-Gabaglia C; Norori P; Santos RG; Giulianotti MA; Slifka MK; Douek DC; Graham BS; Pinilla C PLoS One; 2011; 6(9):e24091. PubMed ID: 21931646 [TBL] [Abstract][Full Text] [Related]
7. Human T-cell responses to vaccinia virus envelope proteins. Tang J; Murtadha M; Schnell M; Eisenlohr LC; Hooper J; Flomenberg P J Virol; 2006 Oct; 80(20):10010-20. PubMed ID: 17005679 [TBL] [Abstract][Full Text] [Related]
8. Effect of the deletion of genes encoding proteins of the extracellular virion form of vaccinia virus on vaccine immunogenicity and protective effectiveness in the mouse model. Meseda CA; Campbell J; Kumar A; Garcia AD; Merchlinsky M; Weir JP PLoS One; 2013; 8(6):e67984. PubMed ID: 23785523 [TBL] [Abstract][Full Text] [Related]
9. Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates. Hooper JW; Custer DM; Thompson E Virology; 2003 Feb; 306(1):181-95. PubMed ID: 12620810 [TBL] [Abstract][Full Text] [Related]
10. Targeting the vaccinia virus L1 protein to the cell surface enhances production of neutralizing antibodies. Golden JW; Josleyn MD; Hooper JW Vaccine; 2008 Jun; 26(27-28):3507-15. PubMed ID: 18485547 [TBL] [Abstract][Full Text] [Related]
11. Human CD4+ T cell epitopes from vaccinia virus induced by vaccination or infection. Calvo-Calle JM; Strug I; Nastke MD; Baker SP; Stern LJ PLoS Pathog; 2007 Oct; 3(10):1511-29. PubMed ID: 17937498 [TBL] [Abstract][Full Text] [Related]
12. Humoral Immunity to Primary Smallpox Vaccination: Impact of Childhood versus Adult Immunization on Vaccinia Vector Vaccine Development in Military Populations. Slike BM; Creegan M; Marovich M; Ngauy V PLoS One; 2017; 12(1):e0169247. PubMed ID: 28046039 [TBL] [Abstract][Full Text] [Related]
13. Human cytotoxic T-cell memory: long-lived responses to vaccinia virus. Demkowicz WE; Littaua RA; Wang J; Ennis FA J Virol; 1996 Apr; 70(4):2627-31. PubMed ID: 8642697 [TBL] [Abstract][Full Text] [Related]
14. Parainfluenza virus 5-based vaccine vectors expressing vaccinia virus (VACV) antigens provide long-term protection in mice from lethal intranasal VACV challenge. Clark KM; Johnson JB; Kock ND; Mizel SB; Parks GD Virology; 2011 Oct; 419(2):97-106. PubMed ID: 21885079 [TBL] [Abstract][Full Text] [Related]
15. Identification of protective T-cell antigens for smallpox vaccines. Ando J; Ngo MC; Ando M; Leen A; Rooney CM Cytotherapy; 2020 Nov; 22(11):642-652. PubMed ID: 32747299 [TBL] [Abstract][Full Text] [Related]
16. Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination. Kennedy JS; Frey SE; Yan L; Rothman AL; Cruz J; Newman FK; Orphin L; Belshe RB; Ennis FA J Infect Dis; 2004 Oct; 190(7):1286-94. PubMed ID: 15346340 [TBL] [Abstract][Full Text] [Related]